Annual Shareholders Meeting 2012 22 August 2012 Tony Carter - - - PowerPoint PPT Presentation

▶
annual shareholders meeting 2012
SMART_READER_LITE
LIVE PREVIEW

Annual Shareholders Meeting 2012 22 August 2012 Tony Carter - - - PowerPoint PPT Presentation

Oct 23, 2023 350 likes •605 views

Annual Shareholders Meeting 2012 22 August 2012 Tony Carter - Chairman 2 Directors Tony Carter (Chairman) Michael Daniell (Managing Director & CEO) Nigel Evans Roger France Lindsay Gillanders Arthur Morris

slide-1
SLIDE 1

Annual Shareholders’ Meeting 2012

22 August 2012

slide-2
SLIDE 2

2

Tony Carter - Chairman

slide-3
SLIDE 3
  • Tony Carter (Chairman)
  • Michael Daniell (Managing Director & CEO)
  • Nigel Evans
  • Roger France
  • Lindsay Gillanders
  • Arthur Morris
  • Gary Paykel

Directors

3

slide-4
SLIDE 4

Annual Shareholders’ Meeting 2012

22 August 2012

4

slide-5
SLIDE 5

10 Years On

5

slide-6
SLIDE 6

Annual Shareholders’ Meeting 2012

22 August 2012

6

slide-7
SLIDE 7

7

Our International Presence

slide-8
SLIDE 8

Annual Shareholders’ Meeting 2012

22 August 2012

8

slide-9
SLIDE 9

9

Michael Daniell – MD/CEO

slide-10
SLIDE 10
  • Innovative devices which

improve care and outcomes

  • Increase value per patient
  • International expansion
  • New clinical applications

Consistent Growth Strategy

US $ Millions Operating Revenue 07 229.1 271.5 299.3 341.5 371.0 417.1 08 09 10 11 12

10

slide-11
SLIDE 11

Financial Summary

12 Months Ended

31 March 2011

12 Months Ended

31 March 2012 % Change

Operating Revenue (NZ$m) 506.1m 516.7m +2% Operating Revenue (Constant Currency) 475.0m 514.1m +8% Operating Margin 19% 18% Net Profit (NZ$m) 63.9m 64.1m

  • Net Profit (Constant Currency)

39.8m 48.9m +23%

11

slide-12
SLIDE 12

Product Groups

  • Consumable and accessory

products 75% of core product revenue

Operating revenue 12 months to 31 March 2012 12

slide-13
SLIDE 13

Global Sales

Operating revenue 12 months to 31 March 2012

  • Sales in more than 120

countries

  • 99% outside New Zealand

13

slide-14
SLIDE 14

Respiratory & Acute Care

14

slide-15
SLIDE 15

New Applications Growing

15

slide-16
SLIDE 16

16

slide-17
SLIDE 17

17

slide-18
SLIDE 18

Obstructive Sleep Apnea

18

slide-19
SLIDE 19

Novo Premo Auto

19

slide-20
SLIDE 20

20

slide-21
SLIDE 21

21

slide-22
SLIDE 22

Earnings Growth Drivers

  • Accelerating revenue growth
  • New products, increased margins
  • Capacity increase in Mexico
  • Lean manufacturing, automation,

supply chain optimisation

  • Reduced expense growth rate
  • Currency diversification
  • Foreign exchange hedging

Mexico facility

22

slide-23
SLIDE 23

23

slide-24
SLIDE 24

24

Outlook

  • Operating revenue

– NZ$265 million approx.

  • Profit after tax

– NZ$31 million approx. First Half

  • Expect over NZD:USD exchange rate

range of 0.78 - 0.82 – Operating revenue NZ$540M - NZ$550M – Net profit after tax NZ$65M - NZ$69M Full Year

slide-25
SLIDE 25

Annual Shareholders’ Meeting 2012

22 August 2012

25